Back to Search Start Over

The nuclear GYF protein CD2BP2/U5-52K is required for T cell homeostasis.

Authors :
Bertazzon, Miriam
Hurtado-Pico, Almudena
Plaza-Sirvent, Carlos
Schuster, Marc
Preußner, Marco
Kuropka, Benno
Fan Liu
Amandus Kirsten, Andor Zenon
Xiao Jakob Schmitt
Benjamin König
Álvaro-Benito, Miguel
Abualrous, Esam T.
Albert, Gesa I.
Kliche, Stefanie
Heyd, Florian
Schmitz, Ingo
Freund, Christian
Source :
Frontiers in Immunology; 2024, p1-17, 17p
Publication Year :
2024

Abstract

The question whether interference with the ubiquitous splicing machinery can lead to cell-type specific perturbation of cellular function is addressed here by T cell specific ablation of the general U5 snRNP assembly factor CD2BP2/U5-52K. This protein defines the family of nuclear GYF domain containing proteins that are ubiquitously expressed in eukaryotes with essential functions ascribed to early embryogenesis and organ function. Abrogating CD2BP2/U5-52K in T cells, allows us to delineate the consequences of splicing machinery interferences for T cell development and function. Increased T cell lymphopenia and T cell death are observed upon depletion of CD2BP2/U5-52K. A substantial increase in exon skipping coincides with the observed defect in the proliferation/differentiation balance in the absence of CD2BP2/U5-52K. Prominently, skipping of exon 7 in Mdm4 is observed, coinciding with upregulation of pro-apoptotic gene expression profiles upon CD2BP2/U5-52K depletion. Furthermore, we observe enhanced sensitivity of naïve T cells compared to memory T cells to changes in CD2BP2/U5-52K levels, indicating that depletion of this general splicing factor leads to modulation of T cell homeostasis. Given the recent structural characterization of the U5 snRNP and the crosslinking mass spectrometry data given here, design of inhibitors of the U5 snRNP conceivably offers new ways to manipulate T cell function in settings of disease. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
179781718
Full Text :
https://doi.org/10.3389/fimmu.2024.1415839